Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Dec 2;26(51):6645-54.
doi: 10.1016/j.vaccine.2008.09.029.

Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals

Affiliations

Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals

J C Lima-Junior et al. Vaccine. .

Abstract

Antibody and T-cell reactivities to Plasmodium vivax merozoite surface protein 9 (PvMSP9) were evaluated in a cross-sectional study of individuals naturally exposed to malaria infections living in Ribeirinha, a native riverine community and in Colina, a transmigrant community, Rondonia, Brazil. The antibody responses to PvMSP9-RIRIIand PvMSP9-Nt domains in Ribeirinha were higher compared with Colina and correlated with age and time of malaria exposure. IgG2 was most prevalent for PvMSP9-RII in both communities, and IgG1 was the predominant isotype for PvMSP9-Nt and PvMSP9-RIRII in Ribeirinha. IFN-gamma and IL-4 predominated in Ribeirinha, while IFN-gamma predominated in Colina. Variation in exposure to P. vivax likely accounts for the differences observed in cytokine and antibody levels between the two populations studied.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic representation of PvMSP9, the constructs of recombinant proteins used for serological analysis (continuous lines) and the synthetic peptides used for cellular analysis (discontinuous lines).
Figure 2
Figure 2
Antibody responses to the recombinant proteins PvMSP9-RIRII, PVMSP9-RII and PvMSP9-Nt in malaria exposed individuals from Colina (CO) and Ribeirinha (RI). (a) Frequency of IgG positive individuals to the recombinant proteins. (*) indicate that the difference was significant (p<0.0001) for a comparison between the frequency of responders from Colina with Ribeirinha by χ2 test; (b) IgG antibodies measured as mean reactivity indexes in responders (mean ± 95% confidence interval). (+) indicate that the difference was significant (p<0.05) for a comparison between the mean RI values responders from Colina with Ribeirinha by Student’s t test; (c) Frequency of IgG subclass distribution in IgG positive individuals. (#) indicates that the difference was significant (p<0.01) for a comparison between a particular IgG subclass over the others IgG subclasses for the same recombinant protein.
Figure 3
Figure 3
Spearman’s rank correlation between time of residence in malaria endemic area and the IgG reactivity index against PvMSP9-RIRII and PvMSP9-RII in Colina (a and c) and Ribeirinha (b and d) population.
Figure 4
Figure 4
Elispot IFN-γ and IL-4 responses to PvMSP9 synthetic peptides (pE, pH, pJ, pK and pL) in individuals naturally exposed to malaria infection from Colina and Ribeirinha. Frequency of IFN-γ and IL-4 responders for each peptide in individuals from Colina (a) and Ribeirinha (b). (*) Indicates that the difference was significant (p<0,01) for a comparison between the frequency of IFN-γ responders with IL-4 responders for each peptide calculated by χ2 test.

Similar articles

Cited by

References

    1. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax malaria: neglected and not benign. Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):79–87. - PMC - PubMed
    1. Baird JK. Neglect of Plasmodium vivax malaria. Trends Parasitol. 2007 Nov;23(11):533–9. - PubMed
    1. Krotoski WA, Collins WE, Bray RS, Garnham PC, Cogswell FB, Gwadz RW, et al. Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection. Am J Trop Med Hyg. 1982 Nov;31(6):1291–3. - PubMed
    1. Canessa A, Mazzarello G, Cruciani M, Bassetti D. Chloroquine-resistant Plasmodium vivax in Brazil. Trans R Soc Trop Med Hyg. 1992 Sep-Oct;86(5):570–1. - PubMed
    1. de Santana Filho FS, Arcanjo AR, Chehuan YM, Costa MR, Martinez-Espinosa FE, Vieira JL, et al. Chloroquine-resistant Plasmodium vivax, Brazilian Amazon. Emerg Infect Dis. 2007 Jul;13(7):1125–6. - PMC - PubMed

Publication types

MeSH terms